Au­to-in­jectable drug mak­er Ak­ti­vax cuts 70 jobs, shuts two sites as it trims scale-up plans

Ak­ti­vax Phar­ma is shut­ting most op­er­a­tions, clos­ing two out of three fa­cil­i­ties and lay­ing off 70 em­ploy­ees due to what the drug au­to-in­jectable man­u­fac­tur­er refers to as “un­ex­pect­ed cir­cum­stances.”

“Un­for­tu­nate­ly, some of our plan­ning as­sump­tions were not re­al­ized and we had to cur­tail our scale-up plans for the time be­ing, which has led us to re­duce our work­force un­til con­di­tions change,” CEO Amir Genosar said in a state­ment to End­points News.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER